Navigation Links
MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
Date:11/14/2011

GAITHERSBURG, Md., Nov. 14, 2011 /PRNewswire/ -- MedImmune today announced the winners of its 6th Annual Research Abstract Competition highlighting the work of the next generation of scientific leaders performing research in the areas of respiratory, inflammatory and autoimmune (RIA) disease. Graduate students and postdoctoral fellows were invited to submit abstracts about RIA research as part of a competition sponsored by MedImmune, the global biologics arm of AstraZeneca.

First prize of $2,000 was awarded to Philippe LeBlanc of Department of Medicine, McGill University, Montreal, Canada, for his research topic, Caspase-1 processes HMGB1 into an immunogenic peptide that signals through RAGE.

LeBlanc noted, "Thank you to all the friendly staff at MedImmune who organized this conference and provided an important opportunity for academia to interface with the private research sector. Many congratulations and thanks to the other participants for sharing their excellent work."

Second and third prizes of $1,000 and $500 were awarded respectively to Jillian Barlow, Laboratory of Molecular Biology, Medical Research Council, Cambridge, UK, and Xiangping Yang, Ph.D, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.

Launched in 2006, MedImmune's Annual Research Abstract Competition aims to engage emerging scientists in health and science education to cultivate a competitive environment that nurtures future research in key therapeutic areas. In 2009, following the success of the RIA abstract competition in the U.S., MedImmune introduced a similar effort in Europe to acknowledge advances in the field of oncology. Since its inception, the MedImmune Annual Research Competition has received more than 330 research abstracts from across the globe.

"We are continuously impressed with the quality of submissions put forth by these young scientists each year," said Bing Y
'/>"/>

SOURCE MedImmune
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Immune Design Grants Adjuvant License to MedImmune
2. MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology
3. Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
4. HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)
5. MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
6. MedImmune Announces Zook as President
7. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
8. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
9. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
10. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
11. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ANGELES , Aug. 4, 2015   California ... the recent acquisition of LifeLine Cryogenics, an east coast ... New York tristate area. LifeLine ... and all prepaid contracts will be honored. ... cryogenics services, offering storage of sperm, eggs, embryos, and ...
(Date:8/3/2015)... 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: HALO ... the second quarter 2015 on Monday, August 10, 2015 ... Torley , president and chief executive officer, will lead ... release financial results for the second quarter 2015. ... "Investors" section of Halozyme,s corporate website and a recording ...
(Date:8/3/2015)... , August 3, 2015 ... Portland Hospital waved the shortfall of ... could stand normally for the first time. ... (Photo: http://photos.prnewswire.com/prnh/20150803/254229 ) The Selective ... legs allowing him to carry out his wish to ...
(Date:8/3/2015)... London, UK (PRWEB) , ... August 03, 2015 ... ... largest consumer of benzene. Benzene is processed to get such derivatives as ethylbenzene, ... Ethylbenzene derivatives are principally used within the automotive industry for the production of ...
Breaking Biology Technology:FamilyCord Announces Acquisition of LifeLine Cryogenics 2Halozyme to Host Second Quarter 2015 Financial Results Conference Call 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 2World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 3
... Pharmaceutical Inc.,("Dragon" or the "Company" TSX: DDD; ... company, today announced it has retained,cQuest, a ... facilitate,and execute its investor and media relations ... capitalizations of less than $200,million to achieve ...
... March 17 STAAR Surgical,Company (Nasdaq: STAA ... invasive ophthalmic products, today announced that the Afinity,Collamer(R) ... been,designated as a New Technology Intraocular Lens (NTIOL) ... To receive NTIOL recognition an IOL,must first be ...
... &,Associates (LE&A) today announced it has added the West ... of health care clients., Based in Grand Rapids, ... state,s largest investor relations firm. The firm,will provide public ... life science industry is growing at a rapid rate ...
Cached Biology Technology:Dragon retains leading investor relations firm 2Dragon retains leading investor relations firm 3STAAR Surgical's Collamer(R) IOL Designated as a New Technology Intraocular Lens by the Centers for Medicare and Medicaid Services 2STAAR Surgical's Collamer(R) IOL Designated as a New Technology Intraocular Lens by the Centers for Medicare and Medicaid Services 3STAAR Surgical's Collamer(R) IOL Designated as a New Technology Intraocular Lens by the Centers for Medicare and Medicaid Services 4Lambert, Edwards & Associates Named Agency of Record for The West Michigan Science & Technology Initiative 2
(Date:7/31/2015)... 31. juli 2015 Den 10. internationale konference ... BGI fra den 22. - 25. oktober i ... sin 10-års fødselsdag i år. Siden starten i 2006 ... møder på ,omik,-feltet, og er en af de mest ... ICG-10 fokuserer på nylige gennembrud og fremskridt inden for ...
(Date:7/31/2015)... , 31 de julho de 2015 A ... www.icg-10.org ) será realizada pela BGI de 22-25 de outubro ... A conferência está celebrando seu 10 o. ... a ICG se tornou uma das reuniões mais influentes ... encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julio de 2015 /PRNewswire/ ... www.icg-10.org ) se celebrará por medio de BGI del 22 ... China . Este año, la conferencia ... 2006, ICG se ha convertido en una de las reuniones ... de ser una de las reuniones más dinámicas, entusiastas y ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... power a large electric grid 99.9 percent of the ... expenses, according to new research by the University of ... combination of wind power, solar power and storage in ... demands while keeping costs low, the scientists found. ...
... insight into evolutional biology by tracing directionality in gene migration ... Masucci from the Centre for Advanced Spatial Analysis, at University ... genes that a marine plant underwent during its evolution. They ... populations of a marine plant went westward from the Mediterranean ...
... Radiation and chemotherapy can pack a powerful punch against ... often left with bad news: Their treatments have rendered ... that it is possible to remove testicular stem cells ... later, after cancer treatments, transplant these cells where they ...
Cached Biology News:Renewables and storage could power grid 99.9 percent of the time 2Renewables and storage could power grid 99.9 percent of the time 3Tracking gene flow in marine plant evolution 2Stem cell research provides hope for infertile cancer survivors 2
6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein, succinimidyl ester (6-HEX, SE) *single isomer*...
... Synthetic peptide derived from the C-terminal ... Specificity: Specific for the junctophilin-2 protein. ... skeletal muscle homogenates frozen mouse skeletal ... Immunohistochemistry(froz) ImmunofluorescenceStorage: Store at -20C for ...
Laminin gamma-2 (G-16)...
ABIN-2 Polyclonal Ab 100 ug rabbit polyclonal antibody. Detects ABIN-2 in human/mouse. Tested in WB....
Biology Products: